Lactobacillus paracasei CCFM1223 Protects against Lipopolysaccharide-Induced Acute Liver Injury in Mice by Regulating the “Gut–Liver” Axis

Abstract

Background: Lactobacillus paracasei CCFM1223, a probiotic previously isolated from the healthy people’s intestine, exerts the beneficial influence of preventing the development of inflammation. Methods: The aim of this research was to explore the beneficial effects of L. paracasei CCFM1223 to prevent lipopolysaccharide (LPS)-induced acute liver injury (ALI) and elaborate on its hepatoprotective mechanisms. Results: L. paracasei CCFM1223 pretreatment remarkably decreased the activities of serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in mice with LPS treatment and remarkably recovered LPS-induced the changes in inflammatory cytokines (tumor necrosis factor-α (TNF-α), transforming growth factor-β (TGF-β), interleukin (IL)-1β, IL-6, IL-17, IL-10, and LPS) and antioxidative enzymes activities (total antioxidant capacity (T-AOC), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and catalase (CAT)). Metagenomic analysis showed that L. paracasei CCFM1223 pretreatment remarkably increased the relative abundance of Catabacter compared with the LPS group but remarkably reduced the relative abundance of [Eubacterium] xylanophilumgroup, ASF356, LachnospiraceaeNK4A136group, and Lachnoclostridium, which is closely associated with the inflammation cytokines and antioxidative enzymes. Furthermore, L. paracasei CCFM1223 pretreatment remarkably increased the colonic, serum, and hepatic IL-22 levels in ALI mice. In addition, L. paracasei CCFM1223 pretreatment remarkably down-regulated the hepatic Tlr4 and Nf-kβ transcriptions and significantly up-regulated the hepatic Tlr9, Tak1, Iκ-Bα, and Nrf2 transcriptions in ALI mice. Conclusions: L. paracasei CCFM1223 has a hepatoprotective function in ameliorating LPS-induced ALI by regulating the “gut–liver” axis.

Selenium-containing soybean peptides ameliorate intestinal inflammation and modulate gut microbiota dysbacteriosis in DSS-induced ulcerative colitis mice

“…57 Lachnospiraceae_NK4A136_group was shown to be negatively correlated with the levels of inflammatory cytokines. 59 Additionally, some intestinal pathogens have been shown to involve in inflammatory responses; Bacteroides could specifically activate NF-κB, and induce the nuclear translocation of the NF-κB-p65 subunit and the expressions of various cytokines and chemokines, such as IL-6, IL-8, CXCL-10 and MCP-1 genes. 60 As shown in Fig.…”

Mitigation of Dextran-Sodium-Sulfate-Induced Colitis in Mice through Oral Administration of Microbiome-Derived Inosine and Its Underlying Mechanisms

“…Additionally, TNF-α has the capability to promote the productions of IL-6 and IL-1β [ 22 ]. The accumulation of IL-6 exacerbates local inflammation and destroys organ function by affecting the energy metabolism [ 23 ]. IL-1β serves as the vital pro-inflammatory cytokine that mainly stems from activated macrophages and promotes the development of colitis by increasing the intestinal permeability [ 4 ].…”

Uvaol Inhibits Inflammatory Response and Prevents Lipopolysaccharide-Induced Acute Lung Injury in Mice

“…IL-6 is a critical mediator in LPS-induced ALI, in addition to its essential role in inflammation and cell-mediated immunity. 34 IL-6 stands out as a very active cytokine that contributes significantly to inflammation. Several clinical problems, including lung damage leading to acute respiratory distress syndrome, often accompany LPS exposure and an increase in IL-6 levels.…”